Chemotherapy‐induced skin toxicity and capillary leak syndrome
Manrup K. Hunjan MBChB  Somaira Nowsheen PhD  Alvaro J. Ramos‐Rodriguez MD  Alina G. Bridges MD  Julia S. Lehman MD  Shahrukh K. Hashmi MD  Rokea A. el‐Azhary MD, PhD
First published: 07 March 2019 https://doi.org/10.1111/ijd.14392
Funding: None.
Conflicts of interest: None.
Read the full text
ePDFPDFTOOLS SHARE
Abstract
Background
The occurrence of chemotherapy‐related adverse cutaneous reactions in the setting of capillary leak syndrome (CLS) is quite rare. Our objective was to identify the type of skin reactions associated with CLS.

Methods
Leukemia or hematopoietic stem cell transplant patients between January 2010 and December 2017 were identified, and medical records were reviewed for a dermatology consultation occurring concomitantly with CLS.

Results
Five patients were identified, two with a diagnosis of toxic erythema of chemotherapy (TEC) and three others with a skin diagnosis of toxic epidermal necrolysis (TEN). Pathology of all patients was available for clinical‐pathologic confirmation.

Conclusions
Although TEC is generally self‐limited, both TEC and TEN can present with severe adverse skin manifestations during CLS secondary to toxicity from chemotherapy.